Page 50 - Drug Discovery and Development: Prospects and Challenges
P. 50

40  /  Drug Discovery and Development: Prospects and Challenges

             Sejahtera Academic Framework (Borhan et al., 2021), IIUM has outlined
             a transformation concept on humanising education for Rahmatan lil-
             alamin. In the context of humanising education, IIUM introduced the
             tagline ‘Khalifah, Amanah, Iqra’, Rahmatan lil-Alamin’ (KhAIR) to be
             adopted as part of the graduate attributes. The KhAIR tagline is an Arabic
             word, which translates for “good”. The KhAIR concept is a simplified
             expression of the seven IIUM missions and it is hoped that the efforts
             will contribute to the development of successful and well balanced IIUM
             graduates post-COVID-19.

             Brothers and sisters,
             Ladies and Gentlemen,


                                     Conclusion

             Drug discovery and development are costly and timely. It takes 12–15
             years and over USD 1 billion just to produce a single drug for a particular
             disease. The failure rate is extremely high with only one would be
             available in the market out of the thousands of drug candidates tested.
             Despite its significant challenge to producing a safe and effective drug,
             the process continues to achieve success thanks to the combined efforts
             of the academic world and private industry. Driven by medical needs
             and the emergence of new diseases, research on new drugs involves
             the translation of basic scientific findings from a laboratory setting into
             human use. Seyhan stated several reasons that impede the continuous
             development of drugs, including poor hypothesis, irreproducible data,
             ambiguous pre-clinical models, inappropriate statistical model, and
             insufficient funding (Seyhan, 2019). These drawbacks may cause a
             translational gap, which later he called as “valley of death” in drug
             discovery and development. Concerning the development of C. asiatica
             for medical use, it is still an on-going process, which requires funding
             and support either from the government or industrial pharmacy for
             further development. We also welcome other researchers to collaborate
             on this project.
   45   46   47   48   49   50   51   52   53   54   55